
## **Trustees’ Annual Report for the Period** 

**From: 1 May 2025 to 30[th] April 2026** 

## **Charity Name: Research and Development Forum** 

## **Charity Registration Number: 1189876** 

## **Objectives and Activities:** 

||<br>SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document.|Para 1.17|The advancement of education and<br>learning in research and development for<br>the health and social care community in<br>England, Scotland, Wales, and Northern<br>Ireland. This will have public benefit in<br>improving the quality and effectiveness of<br>health and social care research.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|The main activity carried out by the CIO is<br>to provide financial support for members of<br>the community to engage in education and<br>learning, which is of benefit to UK health<br>and social care research.<br>Examples of financial support include:<br>contributions to cover costs for community<br>members to attend conferences;<br>contributions to costs for trustees, working<br>group chairs and/or co-chairs to represent<br>the community on national working groups<br>that influence policy with bodies including<br>the Department of Health and Social Care<br>(DHSC), the Health Research Authority<br>(HRA), NHS England (NHSE) and the<br>National Institute for Health and Care<br>Research (NIHR); contributions to costs to<br>facilitate partnering with other organisations<br>and groups across the UK who support<br>health and social care research; and<br>providing funding to cover the essential<br>infrastructure needed to facilitate these<br>interactions.<br>The trustees continue to remain cautious in<br>its approach to allocating and awarding<br>funding. This is due to the ongoing<br>instability in the UK health and social care<br>research system, impacted by changes in<br>national policy, priorities, systems and<br>structures.<br>The trustees are always mindful of the<br>inherent risks due to such instability, and<br>this cautious approach is one way of|





|||mitigating our risk.|
|---|---|---|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit.|Para 1.18|The trustees have regard to the guidance<br>issued by the Charity Commission on<br>public benefit.<br>The CIO funded activities, governance and<br>oversight support a UK-wide community<br>that works together to improve the quality<br>and effectiveness of UK health and social<br>care research which has impact on<br>people’s lives.<br>Equity, diversity, inclusion and belonging<br>continues to be at the forefront of all<br>decision-making for the CIO, as<br>involvement and engagement in UK health<br>and social care research must not and<br>cannot be exclusive.|



## **Additional information (Optional):** You may choose to include further statements where relevant about: 

||SORP reference||
|---|---|---|
|Policy on grant making.|Para 1.38|N/A|
|Policy on social investment<br>including programme related<br>investment.|Para 1.38|N/A|
|Contribution made by<br>volunteers.|Para 1.38|Through the CIO, we have a number of<br>peer-led working groups that provide<br>specialist input on topics such as research<br>finance, contracting, data and AI and<br>research settings.<br>These working groups operate organically<br>– being formed by the community, for the<br>community to address unmet need around<br>specific topics. Members of the working<br>groups are recognised across the UK<br>health and social care research system as<br>experts in their field, often invited to be part<br>of national consultations and projects.<br>Working groups are chaired and co-chaired<br>by volunteers from the R&D community. To<br>recognise their generosity in giving up their<br>time, sharing their expertise, promoting the<br>work of the CIO and leading by example,<br>they are offered either a funded place at<br>the annual conference or a place on one of<br>our training programmes.<br>The volunteers add value and are highly<br>valued by the CIO, as without their support,<br>the CIO would not be where it is today.|
|Other.||N/A|





## **Achievements and Performance:** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|Through the activities of RDF Professional<br>Development Limited, the CIO’s trading<br>arm, we delivered, once again, the largest<br>ever in-person conference to date as well<br>as training opportunities across the UK<br>health and social care research community.<br>The annual conference held in Manchester<br>in May 2025 built on the success of the<br>2024 conference with over 950 delegates<br>from across the UK health and social care<br>research system. It also received record<br>levels of oral and poster abstracts from<br>across the UK health and social care<br>research community, with colleagues keen<br>to share their work.<br>Following the appointment of 4 additional<br>trustees in June 2024, the CIO now has 10<br>trustees who have the collective skills,<br>experience and knowledge that covers the<br>breadth and depth of health and social care<br>research across the UK and is<br>representative of the community it serves.<br>The skills audit that we have adopted as a<br>Board of Trustees is regularly reviewed to<br>ensure we are representative, and if not,<br>agree the action we need to take to remedy<br>this,<br>In line with our approach to the May 2024<br>conference, we offered funding to cover<br>costs of attendance for those in volunteer<br>roles, as well as a paid place for a new<br>entrant to UK research and development to<br>encourage attendance from under-<br>represented groups. We also introduced a<br>50% discount to those who deliver training<br>for the trading subsidiary in recognition of<br>their ongoing support of the CIO.<br>In the year, we offered 5 different training<br>courses, covering 5 topic areas, delivered<br>either in person or online. These courses<br>attracted 87 registrations, and the feedback<br>was very positive. As part of our<br>commitment continuous improvement, the<br>feedback is acted upon to ensure we are<br>meeting the needs, through our training<br>offer, of the community the CIO is there to<br>support.<br>The number of training courses and topic<br>areas is lower than the previous year. This<br>is due to the commencement of a critical|





review of our training offer which includes course content, structure, methods of delivery and cost. This work will be complete in the next reporting period. We continue to buy in specialist administrative and co-ordination support for the CIO from the UK health and social care research system. This investment continues to be instrumental in developing our social media presence and building our HIVE Mind – a peer-led and supported network from across the UK now with over 500 members which shares best practice, peer support and information in a supportive way. This is a 67% increase from the previous year. The HIVE Mind monthly online session regularly has over 70 attendees – a 40% increase from the previous year. In response to community demand, we have stepped up dedicated information sharing sessions for research study set-ups. These sessions attract over 100 attendees and are well received. The specialist support role has also been working closely with the Chair in testing out new platforms that will better support the community. Microsoft Teams will be introduced in the next reporting period to support the activities of the trustees, working groups, HIVE Mind, training, conference, symposia and any other activities which require a software solution which makes it as easy as possible to engage and connect. Our working groups are regularly invited to be part of national policy reviews and updates, ensuring the voice of the community is at the table, has influence, and is being heard. For example, the Research Finance Working Group was involved in the updated NHS England Research Finance Guidance that will be published later this year, the Research Management Working Group fed into the NHS England Leadership and Management Framework that will also be published later this year and the members from across the Working Groups have been informing the policy, funding and operational discussions in relation to streamlining study set-up. In year, the trustees took the decision to focus social media activity away from X and towards BlueSky and LinkedIn. This is 



in line with stakeholder behaviour, with LinkedIn now becoming the ‘platform of choice’. As at the end of the reporting period, the number of LinkedIn followers had increased to 5,180, and in April 2026, our posts made 54,840 impressions. 

## **Additional Information (Optional):** 

|**Additional Information (Optional):**|**Additional Information (Optional):**|**Additional Information (Optional):**|
|---|---|---|
|You may choose to include further statements where relevant about:|||
|Achievements against<br>objectives set.|Para 1.41|N/A|
|Performance of fundraising<br>activities against objectives<br>set.|Para 1.41|N/A|
|Investment performance<br>against objectives.|Para 1.41|N/A|
|Other.||N/A|





## **Financial Review:** 

|**Financial Review:**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period.|Para 1.21|As we continue to invest in the business,<br>profile raising and engagement of the CIO<br>volunteers to create the firm foundation to<br>build on, the movement in reserves was<br>planned.<br>However, such movement will not be<br>recurrent.<br>Financial sustainability continues to be a<br>priority for the trustees, and there is greater<br>scrutiny of the direct and overhead costs of<br>our trading activities. This has been<br>supported by the appointment of new<br>directors to the subsidiary company in year<br>who will work hard to ensure we maximise<br>surpluses from activities so the CIO can<br>achieve its objectives.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held.|Para 1.22|Sustainability of the CIO and meeting the<br>needs of the community is a high priority for<br>the trustees. The UK health and social care<br>research system is in a state of flux, and<br>financial pressures in the system can<br>impact on their ability to investment in its<br>workforce through education and learning –<br>our main source of income.<br>To ensure the CIO is able to operate in the<br>event of a material reduction in our income,<br>which could result from funding challenges<br>in and across the UK health and social care<br>research system, reserves to cover 12<br>months operating costs will be held as a<br>mitigation.<br>We will be introducing an investment<br>strategy and financial reserves policy in<br>2026/27 to formalise this approach.|
|Amount of reserves held.|Para 1.22|£322,728|
|Reasons for holding zero<br>reserves.|Para 1.22|N/A|
|Details of fund materially in<br>deficit.|Para 1.24|N/A|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern.|Para 1.23|Longevity for the CIO is a high priority, and<br>part of planning for this is a prudent<br>approach to financial management and<br>maintaining a level of reserves that would<br>allow the CIO to function without any new<br>income for a period of 12 months.<br>Training and conferences continue to be<br>well attended, and through active<br>monitoring and feedback loops, we respond|





to the needs of our community. We are also actively involved in national discussions with funders and policy makers to ensure we respond to the needs of the wider UK health and social care research system, highlighting the CIO is selfsustaining and, that in the current environment, this is a risk. Having such honest and transparent discussions is essential to our continuity and longevity. 

## **Additional Information (Optional):** 

|**Additional Information (Optional):**|**Additional Information (Optional):**|**Additional Information (Optional):**|**Additional Information (Optional):**|
|---|---|---|---|
|You may choose to include further statements where relevant about:||||
|<br>The charity’s principal<br>sources of funds (including<br>any fundraising).|<br>Para 1.47|<br>Surplus from the ann<br>training activity**.**|ual conference and|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted.|Para 1.46|N/A||
|A description of the principal<br>risks facing the charity.|Para 1.46|The annual conferen<br>generating forecast<br>training offer planne<br>2027 may not realise|ce in May 2026 not<br>surplus and the new<br>d in late 2026 and into<br>funds anticipated.|
|Other.||N/A||



|**Additional Information (Optional):**|**Additional Information (Optional):**|**Additional Information (Optional):**|**Additional Information (Optional):**|
|---|---|---|---|
|You may choose to include further statements where relevant about:||||
|<br>The charity’s principal<br>sources of funds (including<br>any fundraising).|<br>Para 1.47|<br>Surplus from the ann<br>training activity**.**|ual conference and|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted.|Para 1.46|N/A||
|A description of the principal<br>risks facing the charity.|Para 1.46|The annual conferen<br>generating forecast<br>training offer planne<br>2027 may not realise|ce in May 2026 not<br>surplus and the new<br>d in late 2026 and into<br>funds anticipated.|
|Other.||N/A||





## **Structure, Governance and Management:** 

|<br>Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing<br>document.|Para 1.25|Research and Development Forum<br>Constitution.|
|How is the charity<br>constituted?|Para 1.25|Charitable Incorporated Organisation.|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees.|Para 1.25|Any vacancies on the Board of Trustees<br>are openly advertised through the working<br>groups and our monthly newsletter which<br>has 2,870 subscribers. Where necessary,<br>we reference any specific skills, knowledge<br>or experience that we feel is required. This<br>is informed through the annual review of<br>the Trustees skills matrix and terms of<br>office.<br>The Constitution allows up to 12 trustees,<br>and at the end of this reporting period, we<br>have 10 in post. We will be ensuring, as is<br>good practice, to have a staggered<br>approach to replacement, thus ensuring<br>continuity on the Board.<br>As we become more mature, more<br>representative of the community we serve<br>and more future-focussed, we will, through<br>the review of the skills audit, continue to be<br>more targeted in our recruitment of<br>trustees.<br>All trustees are, and always will be,<br>engaged in the recruitment and selection<br>process for any additional or replacement<br>trustees.|



## **Additional Information (Optional):** You may choose to include further statements where relevant about: 

|<br>Policies and procedures<br>adopted for the induction<br>and training of trustees.|<br>Para 1.51|<br>New trustees will be directed to the:<br>•<br>Charity Commission’s ‘Roles and<br>Responsibilities of trustees’ guidance<br>•<br>Constitution.<br>•<br>Trustees annual report and financial<br>statements<br>•<br>Previous minutes of the trustee<br>meetings<br>New trustees will be given:<br>•<br>Full access to dedicated shared<br>platform for CIO business (Future NHS)<br>•<br>Ongoing peer support from current<br>trustees|
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the|Para 1.51|The CIO has a Board of 10 trustees from<br>across the UK, with 1 of the trustees acting<br>as Chair. The Board is supported by a part-|





|charity works.||time co-ordinator.<br>The Board meets monthly, online, and has<br>a clear agenda, from which minutes and<br>actions are taken and progressed.<br>The Board operates under a Compact,<br>informed by the Nolan Principles, setting<br>the expected behaviours of how the<br>trustees and co-ordinator will work together,<br>as well as with key stakeholders.<br>Every quarter, the Board meets online with<br>the Chairs and Co-Chairs of the working<br>groups to ensure there is good<br>communication flows between and across<br>them all groups.<br>The culture is one where every voice<br>matters, and these voices inform decisions<br>made.<br>The CIO does not directly employ any staff<br>- it buys in services needed to allow it to<br>run, both at an operational and strategic<br>level.|
|---|---|---|
|Relationship with any<br>related parties.|Para 1.51|The CIO has a trading subsidiary – RDF<br>Professional Development Limited, through<br>which it offers conferences, symposia, and<br>training and development opportunities to<br>the UK health and social care research<br>community. An annual charitable donation<br>is made from the trading subsidiary to the<br>CIO to enable it to achieve its charitable<br>objects.<br>The trading subsidiary is supported via a<br>virtual office for its activities and the<br>relationship and has its own, separate,<br>Board of Directors.|
|Other.||N/A|



## **Reference and Administrative Details:** 

|Charity name:|Research and Development Forum|
|---|---|
|Other name the charity uses:|N/A|
|Registered charity number:|1189876|
|Charity’s principal address:|39 Mill Crescent<br>Hebburn<br>Tyne and Wear<br>NE31 1UG|





## **Names of the Charity Trustees Who Manage the Charity:** 

|<br>**Trustee name**|<br>**Office (if any)**|<br>**Dates acted if not for**<br>**whole year**|<br>**Name of person (or**<br>**body) entitled to**<br>**appoint trustee (if**<br>**any)**|
|---|---|---|---|
|Angela Topping|Chair|||
|Carolyn Maloney||||
|Dipak Patel|Treasurer|||
|Margaret Cooper||||
|Mark Brandon-Grove||||
|Philippa Brice||||
|Rachel Gemine||||
|Sean Scott||||
|Shahista Hussain||||
|Shona Haining||||



## **Corporate Trustees – Names of the Directors at the Date the Report Was Approved:** 

|**Was Approved:**||
|---|---|
|<br>**Director name**|**Dates acted if not for whole year**|
|N/A||



## **Name of Trustees Holding Title to Property Belonging to The Charity:** 

|**Charity:**||
|---|---|
|**Trustee name**|**Dates acted if not for whole year**|
|N/A||





## **Funds Held as Custodian Trustees on Behalf of Others:** 

Description of the assets N/A held in this capacity. 

Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects. Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets. 

## **Additional Information (optional):** 

Names and addresses of advisers (optional information): **Type of adviser Name Address** N/A 

Name of chief executive or names of senior staff members (optional information): N/A 

## **Exemptions From Disclosure:** 

Reason for non-disclosure of key personnel details: 

N/A 

## **Other Optional Information:** 

N/A 



## **Declarations:** 

The trustees declare that they have approved the trustees’ report above. 

Signed on behalf of the charity trustees: 

Signature(s): **Full name(s):** Angela Topping **Position:** Chair 

**Date:** 10.11.2026 




**Charity Name No (if any) Research and Development Forum Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 1-May-25 30-Apr-26 

## **Section A Receipts and payments** 

|||**Unrestricted**<br>**funds**|||**Restricted**<br>**funds**||**Endowment**<br>**funds**||**Total funds**||**Last year**||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||**to the nearest**|**£**||**to the nearest £**||**to the nearest £**||**to the nearest £**||**to the nearest £**||
|**A1 Receipts**|||||||||||||
|Transfer of funds trom tradingactivities||**21,224**|||**-**||**-**||**21,224**||**50,000**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
||||**-**||**-**||**-**||**-**||**-**||
|**_Sub total_**_(Gross income for AR)_||**21,224**<br>|||**-**||**-**||**21,224**||**50,000**||



|**Section A Receipts and payments**|**Section A Receipts and payments**|||||
|---|---|---|---|---|---|
|**A1 Receipts**<br>Transfer of funds trom tradingactivities<br>**21,224**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**21,224**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**21,224**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**21,224**|**Last year**<br>**to the nearest £**|
|Transfer of funds trom tradingactivities|**21,224**|**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**21,224**|**50,000**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
||**-**|**-**||**-**|**-**|
|**_Sub total_**_(Gross income for AR)_|**21,224**<br>|**-**||**21,224**|**50,000**|
|**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                   21,224**<br>**A3 Payments**<br>Expenses<br>**3,912**<br>External Services - Co-ordination<br>**21,960**<br>External Services - Oversight<br>**33,583**<br>Grant Funding- RDF26 Contribution<br>**20,418**<br>External Services - Retender<br>**197**<br>Grant Funding- RDF25 Contribution<br>**-**<br>Grant Funding- RDF24 Contribution<br>**-**<br>Postage<br>**-**<br>**-**<br>**_Sub total_                      80,070**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                   80,070**<br>**_Net of receipts/(payments)_ -                58,846**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**381,574**<br>**_Cash funds this year end_                 322,728**<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**-**<br>**-**<br>**-**<br>**21,224**<br>**3,912**<br>**21,960**<br>**33,583**<br>**20,418**<br>**197**<br>**-**<br>**-**<br>**-**<br>**-**<br>**80,070**<br>**-**<br>**-**<br>**-**<br>**80,070**<br>**-                58,846**<br>**-**<br>**381,574**<br>**322,728**||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**|**-**|
|||||**-**|**-**|
|||||||
||||**-**|**21,224**|**50,000**|
|||||||
||||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**3,912**|**3,701**|
|||||**21,960**|**41,965**|
|||||**33,583**|**13,000**|
|||||**20,418**|**-**|
|||||**197**|**-**|
|||||**-**|**29,154**|
|||||**-**|**14,454**|
|||||**-**|**4**|
|||||**-**|**-**|
|||||**80,070**|**102,278**|
|||||||
||||**-**<br>**-**<br>**-**|**-**||
|||||**-**||
|||||**-**|**-**|
|||||||
||||**-**|**80,070**|**102,278**|
|||||||
|||**-**|**-**<br>**-**<br>**-**<br>**-**|**-                58,846**|**-               52,278**|
|||**-**||**-**|**-**|
|||**-**||**381,574**|**433,852**|
|||**-**||**322,728**|**381,574**|



## **Section B Statement of assets and liabilities at the end of the period** 

**Categories Details B1 Cash funds** _**Total cash funds**_ 

|**to nearest £**<br>**Unrestricted**<br>**funds**|**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|
|**322,728**<br>**-**<br>**-**<br>**322,728**|**-**|**-**|
||**-**|**-**|
||**-**|**-**|
||**-**|**-**|



CCXX R1 accounts (SS) 

11/11/2026 

1 



|**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>(agree balances with receipts and payments<br>account(s))|OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Angela Topping<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|OK|
|---|---|---|---|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
|||||
||||Date of<br>approval|
|||Angela Topping|10/26/2026|
|||||



CCXX R2 accounts (SS) 

11/11/2026 

2 

